Ceramide Synthase 2 (CERS2) (AA 230-261) anticorps (FITC)

Détails pour le produit réf. ABIN709338
Antigène
  • L3
  • LASS2
  • SP260
  • TMSG1
  • 0610013I17Rik
  • AI225939
  • Lass2
  • TRH3
  • ceramide synthase 2
  • CERS2
  • Cers2
Épitope
AA 230-261
14
9
4
1
1
1
1
1
1
Reactivité
Humain, Souris, Rat (Rattus)
71
24
22
8
5
5
5
4
4
4
2
1
1
Hôte
Lapin
50
21
Clonalité
Polyclonal
Conjugué
FITC
3
3
3
3
3
3
3
1
1
1
1
1
1
Application
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
49
15
12
9
6
3
3
2
2
2
1
Options
Immunogène KLH conjugated synthetic peptide derived from human Ceramide synthase 2
Isotype IgG
Purification Purified by Protein A.
Antigène
Autre désignation Ceramide Synthase 2 (CERS2 Antibody Extrait)
Sujet

LASS2 (LAG1 homolog, ceramide synthase 2) has sequence similarity to yeast longevity assurance gene 1. It is thought to be involved in sphingolipid synthesis. Expression of LASS2 is transiently increased during the period of active myelination and is specifically localized to white matter tracts of the brain, including the Schwann cells of sciatic nerves suggesting that LASS2 is important for the synthesis of dihydroceramide used for synthesis of myelin sphingolipids. Expression of LASS2 in hepatocellular carcinoma cell lines suppresses the growth of cancer cells.

Subcellular location: Lumenal

Synonyms: L3, LASS2, SP260, TMSG1, Ceramide synthase 2, CerS2, LAG1 longevity assurance homolog 2, Tumor metastasis-suppressor gene 1 protein

ID gène 29956
UniProt Q96G23
Indications d'application IF(IHC-P) 1:50-200
Restrictions For Research Use only
Format Liquid
Concentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Agent conservateur Sodium azide
Précaution d'utilisation This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Stock 4 °C
Stockage commentaire Store at 4°C
Date de péremption 12 months
Avez-vous cherché autre chose?